Answers are grounded in this paper and cite their sources.
The heterogeneous state and federal insurance laws for oncology clinical trial coverage are confusing for health care providers, patients, and other stakeholders. Clearer explication and education about clinical trial coverage are needed to improve patient access.
No takes yet. Share an insight, caveat, or question.
Obeng‐Gyasi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: